These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dynamic protein interaction modules in human hepatocellular carcinoma progression. Yu H; Lin CC; Li YY; Zhao Z BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S2. PubMed ID: 24564909 [TBL] [Abstract][Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
4. Analysis of potential key genes in very early hepatocellular carcinoma. Wu M; Liu Z; Li X; Zhang A; Lin D; Li N World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166 [TBL] [Abstract][Full Text] [Related]
5. The HOX gene network in hepatocellular carcinoma. Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505 [TBL] [Abstract][Full Text] [Related]
6. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma. Schröder PC; Segura V; Riezu JI; Sangro B; Mato JM; Prieto J; SantamarÃa E; Corrales FJ Funct Integr Genomics; 2011 Sep; 11(3):419-29. PubMed ID: 21562899 [TBL] [Abstract][Full Text] [Related]
7. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. Wang L; Huang J; Jiang M; Zheng X Tumour Biol; 2010 Oct; 31(5):417-25. PubMed ID: 20532728 [TBL] [Abstract][Full Text] [Related]
8. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma. Zhang Y; Tang Y; Guo C; Li G Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043 [TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation. Wang L; Sun L; Huang J; Jiang M Cell Prolif; 2011 Jun; 44(3):291-9. PubMed ID: 21535270 [TBL] [Abstract][Full Text] [Related]
10. [Predication analysis of microarray data to determine altered gene profiles in liver carcinoma related to HBV-related cirrhosis]. Liu J; Zhang Q; Li Z; Zhang Q; Qu Y; Lu L; Xu M Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):625-30. PubMed ID: 25243966 [TBL] [Abstract][Full Text] [Related]
11. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis. He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074 [TBL] [Abstract][Full Text] [Related]
13. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. Zheng S; Tansey WP; Hiebert SW; Zhao Z BMC Med Genomics; 2011 Aug; 4():62. PubMed ID: 21824427 [TBL] [Abstract][Full Text] [Related]
14. Multi-omic analysis identifies the molecular mechanism of hepatocellular carcinoma with cirrhosis. Xuan M; Gu X; Xing H Sci Rep; 2024 Oct; 14(1):23832. PubMed ID: 39394373 [TBL] [Abstract][Full Text] [Related]
15. Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression. Ramesh V; Ganesan K Int J Cancer; 2016 Oct; 139(7):1586-97. PubMed ID: 27194100 [TBL] [Abstract][Full Text] [Related]
16. Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis. Wang F; Chang Y; Li J; Wang H; Zhou R; Qi J; Liu J; Zhao Q Dig Liver Dis; 2017 Jan; 49(1):70-76. PubMed ID: 27876500 [TBL] [Abstract][Full Text] [Related]
17. Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis. Liu S; Zhu P; Zhang L; Ding S; Zheng S; Wang Y; Lu F Cancer Biomark; 2013; 13(5):345-9. PubMed ID: 24440974 [TBL] [Abstract][Full Text] [Related]
18. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846 [TBL] [Abstract][Full Text] [Related]
19. Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas. Seshachalam VP; Sekar K; Hui KM J Gastroenterol Hepatol; 2018 Dec; 33(12):2037-2047. PubMed ID: 29672926 [TBL] [Abstract][Full Text] [Related]
20. Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence. Caillot F; Derambure C; Bioulac-Sage P; Francois A; Scotte M; Goria O; Hiron M; Daveau M; Salier JP World J Gastroenterol; 2009 Jan; 15(3):300-9. PubMed ID: 19140229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]